Alembic Pharma Share Price

₹ 802.80

-₹0.20 (-0.02%)
1D
Last updated 03 Nov, 2026, 15:50 IST
NSE: APLLTD
|
Pharmaceuticals

Alembic Pharma Share Price Today

As of 3 Nov 2026, Alembic Pharma share price is ₹802.80. The stock opened at ₹803.00, compared to its previous close of ₹803.00. During today's trading session, Alembic Pharma share price moved in the range of ₹798.50 to ₹814.85, with an average price of ₹806.67 for the day. Looking at its last 52-week, the stock has touched a low of ₹635.80 and a high of ₹998.00.

Share price over the last 1 day fell from 805.55 to 803.00, ranging between 799.70 and 814.55.
₹798.50
0.02% down today
₹814.85
1D LOW
1D HIGH

Alembic Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 87.03% QoQ
Latest Earning
Net Profit TrendUp by 15.26% YoY
Latest Earning
Revenue TrendUp by 15.56% QoQ
Stock Performance
OutperformingBeat Nifty by 3.98 % in last 3 month
Shareholding Pattern
DIIDII decreased stake by 3.77%
Shareholding Pattern
FIIFII increased stake by 8.75%
Alembic Pharma stock performance
Open₹803.00
High₹814.85
Low₹798.50
Prev. close₹803.00
Alembic Pharma trading activity
Volume92,294
Average traded price₹805.28
Last traded time03:50:41 03 Nov
Last traded quantity30
Circuit
L
H
₹642.40
₹963.60
52-week
L
H
₹635.80
₹998.00
Mkt Cap Cr
15,748.64
P/E
22.84
P/B
2.78
ROA
7.87%
ROE
11.89%
ROCE
10.81%
Quick Ratio
0.78
EV/EBITDA
14.5

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Alembic Pharma has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Alembic Pharma appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Alembic Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Alembic Pharma Company Background

ISIN
INE901L01018
Sector Market Cap
₹ 15,748.64 Cr

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.

Alembic Pharma Financial Highlights

  • Revenue: Alembic Pharma reported revenue of ₹7,399.31 crore in FY26 vs ₹6,714.63 crore in FY25. It showed an increase of 10.20% on a yearly basis.
  • Operating Profit: Alembic Pharma reported an operating profit of ₹693.95 crore in FY26 vs ₹707.18 crore in FY25. It showed a decrease of 1.87% on a year-on-year basis.
  • Net Profit: Alembic Pharma reported a net profit of ₹670.83 crore in FY26 vs ₹582.01 crore in FY25. It showed an increase of 15.26% on a yearly basis.

Alembic Pharma Quarterly Result Highlights

  • Alembic Pharma reported revenue of ₹2,164.70 crore in Jun 2026, compared with ₹1,873.22 crore in Mar 2026, representing an increase of 15.56% on a quarter-on-quarter (QoQ) basis.
  • Alembic Pharma reported an operating profit of ₹221.86 crore in Jun 2026, compared with ₹118.62 crore in Mar 2026, representing an increase of 87.03% on a quarter-on-quarter (QoQ) basis.
  • Alembic Pharma reported a profit of ₹172.36 crore in Jun 2026, compared with ₹201.53 crore in Mar 2026, reflecting a decrease of 14.47% on a QoQ basis.
  • The earnings per share (EPS) of Alembic Pharma stood at ₹34.33 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
69.87%
FII
4.55%
Other DII
6.93%
Retail and other
10.15%
Mutual funds
8.50%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20254.24%
Mar 20264.25%
Jun 20264.18%
Sep 20264.55%

Alembic Pharma Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

Alembic Pharma Share Price History

Alembic Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹801.10 / ₹803.00
+0.65%
30 Oct 26
₹794.85 / ₹797.85
+0.38%
29 Oct 26
₹780.40 / ₹794.85
+1.54%
28 Oct 26
₹769.95 / ₹782.80
+2.07%
Show more

Alembic Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹7,344.90₹6,672.08₹6,228.63₹5,652.62
Other Income₹54.41₹42.55₹28.30₹2.74
Total Revenue₹7,399.31₹6,714.63₹6,256.93₹5,655.36
Total Expenses₹6,638.62₹6,021.20₹5,624.13₹5,269.86
Profit Before Tax₹693.95₹707.18₹631.83₹354.59
Tax₹23.12₹125.17₹16.01₹12.60
Profit After Tax₹670.83₹582.01₹615.82₹341.99
EPS - Basic₹34.33₹29.68₹31.33₹17.40
EPS - Diluted₹34.33₹29.68₹31.33₹17.40

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹693.95₹707.18₹631.83₹354.59
Income before WC changes₹1,143.26₹1,080.71₹918.69₹842.20
Change in Assets-₹265.52-₹1,088.66-₹146.81₹38.70
Change in Liabilities₹8.70₹167.30₹51.17-₹96.26
Change in WC-₹256.82-₹921.36-₹95.64-₹57.56
Cash flow from Operations₹782.73₹87.96₹803.20₹723.95
Cash flow from Investing-₹506.06-₹568.41-₹320.61-₹447.60
Cash flow from Financing-₹163.78₹443.72-₹437.86-₹261.96
Total Cash Flow₹112.89-₹36.73₹44.73₹14.39
Cash (Start of the year)₹83.48₹120.21₹75.48₹61.09
Cash (End of the year)₹196.37₹83.48₹120.21₹75.48

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹4,219.99₹3,685.15₹3,367.02₹3,272.81
Current Assets₹4,542.59₹4,087.80₹3,078.56₹2,910.02
Total Assets₹8,762.58₹7,772.95₹6,445.58₹6,182.83
Current Liabilities₹2,593.83₹2,412.35₹1,454.99₹1,636.93
Net Current Asset₹1,948.76₹1,675.45₹1,623.57₹1,273.09
Non-Current Liabilities₹499.77₹171.08₹172.39₹175.43
Equity Capital₹5,668.98₹5,189.52₹4,818.20₹4,370.47
Total Equity & Liabilities₹8,762.58₹7,772.95₹6,445.58₹6,182.83

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6,651.38₹6,032.63₹5,874.06₹5,149.00
Other Income₹55.90₹47.88₹31.32₹3.55
Total Revenue₹6,707.28₹6,080.51₹5,905.38₹5,152.55
Total Expenses₹5,986.18₹5,484.79₹5,201.15₹4,806.62
Profit Before Tax₹654.11₹608.59₹704.23₹345.93
Tax₹13.69₹105.47₹37.75-₹0.80
Profit After Tax₹640.42₹503.12₹666.48₹346.73
EPS - Basic₹32.58₹25.60₹33.91₹17.64
EPS - Diluted₹32.58₹25.60₹33.91₹17.64

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹654.11₹608.59₹704.23₹345.93
Income before WC changes₹1,082.56₹973.66₹988.44₹794.42
Change in Assets-₹184.71-₹828.50-₹224.36₹33.82
Change in Liabilities-₹8.84₹127.07₹18.72-₹44.21
Change in WC-₹193.55-₹701.43-₹205.64-₹10.39
Cash flow from Operations₹809.47₹226.56₹772.77₹730.25
Cash flow from Investing-₹483.43-₹636.07-₹329.02-₹460.98
Cash flow from Financing-₹317.60₹403.61-₹445.29-₹261.16
Total Cash Flow₹8.44-₹5.90-₹1.54₹8.11
Cash (Start of the year)₹14.23₹20.13₹21.67₹13.56
Cash (End of the year)₹22.67₹14.23₹20.13₹21.67

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹4,150.24₹3,790.07₹3,409.99₹3,350.19
Current Assets₹4,001.00₹3,766.19₹2,988.56₹2,780.23
Total Assets₹8,151.24₹7,556.26₹6,398.55₹6,130.42
Current Liabilities₹2,356.15₹2,199.59₹1,327.22₹1,551.30
Net Current Asset₹1,644.85₹1,566.60₹1,661.34₹1,228.93
Non-Current Liabilities₹179.83₹161.93₹162.42₹164.83
Equity Capital₹5,615.26₹5,194.74₹4,908.91₹4,414.29
Total Equity & Liabilities₹8,151.24₹7,556.26₹6,398.55₹6,130.42
* All values are in INR Crore
Alembic Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Alembic Pharma technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
51.46
Neutral
ATR (14)
18.81
Neutral
STOCH(9,6)
93.67
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
29.01
Bearish
UO(9)
62.03
Neutral
ROC(12)
1.33
Bullish
WillR(14)
-6.33
Bearish
Period
Simple value
Exponential vaue
5D
789.08
792.54
10D
783.15
789.73
20D
794.68
795.68
50D
814.15
806.2
100D
810.19
801.89
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct1L
27 Oct2L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Alembic Pharma
Pharmaceuticals
Add Stock
Add Another

Alembic Pharma Returns Calculator

Ex-date: 29 Jul 2026

Alembic Pharma Latest News

4 months ago
Alembic Pharmaceuticals shares jump 3% as US FDA tentatively approves Larotrectinib capsules
Showing news item 1 of 1

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

Alembic Pharma Share Price FAQs

Please be aware that Alembic Pharma stock prices are subject to continuous fluctuations due to various factors.